How to Read a Peptide COA

Peptide laboratory with microscope, vials, and American flag — quality testing infrastructure

A Certificate of Analysis (COA) is a document issued by a third-party analytical laboratory that reports the purity, identity, and characterization data for a specific batch of a chemical compound. For research peptides, a COA is the single most important piece of evidence you have that the vial in your hand actually contains what the label claims. Marketing copy doesn't matter; the COA does. This guide walks through every section of a peptide COA, what the numbers mean, and how to spot a document that's hiding more than it shows.

Research use only. The information below is provided for in-vitro and laboratory research professionals. None of the compounds or quality standards discussed are intended for human consumption, therapeutic use, or veterinary use. Always follow applicable institutional, federal, and local regulations.

What a Peptide COA Actually Is

A COA is not a marketing document. It is a structured analytical report tied to a single, traceable lot (batch) of material. A legitimate COA will name the compound, identify the batch, report multiple orthogonal analytical methods (typically HPLC for purity and mass spectrometry for identity), state the testing date, and identify the laboratory that performed the work. If any of those elements is missing, the document is not a COA in the meaningful sense — it's a label.

Pharmaceutical-grade analytical practice is governed by published standards. Two of the most commonly referenced are USP General Chapter <232> Elemental Impurities (USP official), which sets permitted daily exposure limits for trace metals across routes of administration, and the ICH Q3C(R8) guideline on residual solvents (harmonized internationally and reflected in USP General Chapter <467>). Research-grade peptide COAs rarely test to full pharmacopoeial standard, but the language and limits these standards define are the reference points that meaningful purity testing borrows from.

How to Read a Peptide COA: Step-by-Step

Work through every COA in the same fixed order. Each step below corresponds to a specific section of the document and a specific question you should be able to answer before you finish reading.

Step 1: Identify the compound name and CAS number

The top of the COA should name the peptide explicitly (e.g., "Tirzepatide") and, where one exists, provide the CAS Registry Number. The CAS number is a unique numeric identifier that removes ambiguity between molecules with similar names or synonyms. If the COA lists only a vague descriptor ("GLP-1 analog") or no CAS number for a compound that has one, treat that as a red flag and ask the supplier to provide the formal identification.

Step 2: Check the lot/batch number against your vial label

Every COA is tied to one specific batch. The lot or batch number on the COA must match — character-for-character — the lot number printed on the vial you actually received. A COA from a different lot tells you nothing about the material in your hand. If the numbers don't match, you have an unverified vial. This is the single most common shortcut suppliers take, and the easiest one to catch.

Step 3: Read the purity result (HPLC area %, should be ≥99%)

High-Performance Liquid Chromatography (HPLC) measures purity by separating the peptide from impurities and integrating the area under each peak. A reputable COA will state the method (typically reverse-phase HPLC at 220 nm), the column, and the result as an area percent — for example, "Purity: 99.4% (HPLC area, 220 nm)." For research peptides, ≥98% is the practical baseline and ≥99% is the standard for sensitive in-vitro work. A chromatogram (the actual trace) should be attached or available on request; a single number with no chromatogram is weaker evidence than a number plus the underlying trace.

Step 4: Read mass spectrometry confirmation (matches expected MW)

HPLC tells you how pure the major peak is; mass spectrometry tells you whether that major peak is actually the molecule it claims to be. The COA should list the theoretical (calculated) molecular weight and the observed (measured) molecular weight. For a correctly identified peptide, the observed mass should match the theoretical mass within roughly 1 Dalton (often much tighter on high-resolution instruments). A 99% pure peak of the wrong molecule is still the wrong molecule — this is the step that catches that error.

Step 5: Check the testing date (recent? within 12 months?)

Peptides are not infinitely stable. Lyophilized powder stored cold and dry is generally stable for long periods, but a COA dated several years before your purchase is weaker evidence than one dated recently. As a rule of thumb, testing dated within the last 12 months is preferred. If the COA is older, the supplier should be able to explain storage conditions and ideally provide a re-test or stability data.

Step 6: Verify the testing lab (third-party? named?)

The COA should name the laboratory that performed the analysis. Third-party (independent) testing is stronger evidence than in-house testing, because the analytical lab has no commercial incentive to inflate purity numbers. Look for a lab name, address, and signatory. An unsigned COA, or one that lists only "QC Department" with no organizational identity, is not third-party verification.

Step 7: Check additional tests if applicable (endotoxin, bioburden, water content)

Beyond HPLC and mass spec, well-characterized peptide COAs may include water content by Karl Fischer titration (typically <10%), counterion content (TFA or acetate salt percentage, which affects net peptide quantity), endotoxin testing (LAL assay, relevant for any application sensitive to bacterial contamination), bioburden (microbial load), and residual solvents. The relevance of each test depends on the intended research use; for purely in-vitro chemical work, HPLC + MS is the minimum, while more sensitive applications benefit from the full panel.

Worked Example: Reading a Real COA Row

Suppose the COA you receive for a vial of tirzepatide contains the following line items:

Compound: Tirzepatide
CAS Number: 2023788-19-2
Lot Number: AP-2026-04-15
Purity (HPLC, 220 nm): 99.4% area
Mass (ESI-MS, observed): 4813.5 Da
Mass (theoretical, monoisotopic average): 4813.5 Da
Water Content (Karl Fischer): 4.2%
Counterion: TFA, 6.1%
Testing Date: 2026-04-18
Laboratory: [Named third-party analytical lab, signed]

Walking through the seven steps: the compound and CAS number are explicit (Step 1); the lot number AP-2026-04-15 is verifiable against the vial (Step 2); 99.4% HPLC area exceeds the 99% threshold for sensitive work (Step 3); observed mass matches theoretical mass to the decimal place (Step 4); the testing date is recent (Step 5); the lab is named and signed (Step 6); and water content and counterion are reported, providing useful additional characterization (Step 7). This is the shape of a COA you can act on.

Now consider the failure mode: a document that reports "Purity: 99%+" with no method, no chromatogram, no mass spec, no lot number, and no signing lab. That is not a COA — that is a label restated in COA-shaped formatting. The numbered steps above are designed to make that distinction unambiguous.

Red Flags Summary

Lot number on COA doesn't match vial
HPLC purity stated without method, wavelength, or chromatogram
No mass spectrometry confirmation of identity
Testing date missing or older than 12 months with no re-test
Laboratory unnamed or marked only "in-house"
COA template identical across multiple unrelated batches (suggests recycled document)

Frequently Asked Questions

What HPLC purity is acceptable for research peptides?

The practical baseline for research-use peptides is ≥98% by HPLC area at 220 nm. For sensitive in-vitro work — receptor binding studies, structure-activity comparisons, anything where minor impurities could confound the readout — ≥99% is the working standard. Below 98%, the impurity profile matters as much as the purity number, and the COA should disclose what the impurities are.

What does mass spec tell you that HPLC doesn't?

HPLC measures how clean a peak is; mass spectrometry measures what that peak is. A 99% pure HPLC peak of the wrong peptide is still 99% pure — and still useless. Mass spec confirms identity by matching observed molecular weight to theoretical molecular weight (typically within 1 Da). HPLC and MS together verify both purity and identity; either alone is incomplete.

How recent should the COA testing date be?

Within the last 12 months is the working preference. Lyophilized peptide powder stored cold and dry is generally stable for longer than that, but a recent test date is stronger evidence than an older one. If a COA is older than 12 months, the supplier should be willing to either re-test or provide documented stability data covering the elapsed time and storage conditions.

What's the difference between HPLC area % and HPLC weight %?

HPLC area percent is the integrated area of the main peak divided by the total area of all peaks in the chromatogram. It assumes (roughly) that all components respond similarly to the UV detector — a reasonable assumption for peptide-related impurities at 220 nm. Weight percent would require quantitation against a reference standard. Almost all peptide COAs report area %; this is the industry-standard convention, and is what "purity by HPLC" means unless stated otherwise.

Should a COA include endotoxin or bioburden testing?

For purely in-vitro chemistry, no — those tests aren't necessary. For research applications involving cell culture or any sensitivity to bacterial contamination, yes, an endotoxin (LAL) result and/or bioburden number adds meaningful safety characterization. If your protocol calls for it, ask before purchase rather than after.